BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Youhanna S, Lauschke VM. The Past, Present and Future of Intestinal In Vitro Cell Systems for Drug Absorption Studies. J Pharm Sci 2021;110:50-65. [PMID: 32628951 DOI: 10.1016/j.xphs.2020.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kakni P, López-iglesias C, Truckenmüller R, Habibović P, Giselbrecht S. Reversing Epithelial Polarity in Pluripotent Stem Cell-Derived Intestinal Organoids. Front Bioeng Biotechnol 2022;10:879024. [DOI: 10.3389/fbioe.2022.879024] [Reference Citation Analysis]
2 Shang H, Sun Y, Wang Z, Zhou Y, Yang H, Ci X, Cui T, Xia Y, Gu Y, Liao M, Li Q, Si D, Liu C. Intestinal absorption mechanism of rotundic acid: Involvement of P-gp and OATP2B1. J Ethnopharmacol 2022;:115006. [PMID: 35051604 DOI: 10.1016/j.jep.2022.115006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lindner M, Laporte A, Block S, Elomaa L, Weinhart M. Physiological Shear Stress Enhances Differentiation, Mucus-Formation and Structural 3D Organization of Intestinal Epithelial Cells In Vitro. Cells 2021;10:2062. [PMID: 34440830 DOI: 10.3390/cells10082062] [Reference Citation Analysis]
4 Zietek T, Boomgaarden WAD, Rath E. Drug Screening, Oral Bioavailability and Regulatory Aspects: A Need for Human Organoids. Pharmaceutics 2021;13:1280. [PMID: 34452240 DOI: 10.3390/pharmaceutics13081280] [Reference Citation Analysis]
5 Pulukuri AJ, Burt AJ, Opp LK, McDowell CM, Davaritouchaee M, Nielsen AE, Mancini RJ. Acquired Drug Resistance Enhances Imidazoquinoline Efflux by P-Glycoprotein. Pharmaceuticals (Basel) 2021;14:1292. [PMID: 34959691 DOI: 10.3390/ph14121292] [Reference Citation Analysis]
6 Dufau J, Shen JX, Couchet M, De Castro Barbosa T, Mejhert N, Massier L, Griseti E, Mouisel E, Amri EZ, Lauschke VM, Rydén M, Langin D. In vitro and ex vivo models of adipocytes. Am J Physiol Cell Physiol 2021;320:C822-41. [PMID: 33439778 DOI: 10.1152/ajpcell.00519.2020] [Reference Citation Analysis]
7 Vincent M, Simon L, Brabet P, Legrand P, Dorandeu C, Him JLK, Durand T, Crauste C, Begu S. Formulation and Evaluation of SNEDDS Loaded with Original Lipophenol for the Oral Route to Prevent Dry AMD and Stragardt’s Disease. Pharmaceutics 2022;14:1029. [DOI: 10.3390/pharmaceutics14051029] [Reference Citation Analysis]
8 Dogan AA, Dufva M. Customized 3D-printed stackable cell culture inserts tailored with bioactive membranes. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-07739-7] [Reference Citation Analysis]
9 Rahman S, Ghiboub M, Donkers JM, van de Steeg E, van Tol EAF, Hakvoort TBM, de Jonge WJ. The Progress of Intestinal Epithelial Models from Cell Lines to Gut-On-Chip. Int J Mol Sci 2021;22:13472. [PMID: 34948271 DOI: 10.3390/ijms222413472] [Reference Citation Analysis]
10 Macedo MH, Barros AS, Martínez E, Barrias CC, Sarmento B. All layers matter: Innovative three-dimensional epithelium-stroma-endothelium intestinal model for reliable permeability outcomes. J Control Release 2021;341:414-30. [PMID: 34871636 DOI: 10.1016/j.jconrel.2021.11.048] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Youhanna S, Kemas AM, Preiss L, Zhou Y, Shen JX, Cakal SD, Paqualini FS, Goparaju SK, Shafagh RZ, Lind JU, Sellgren CM, Lauschke VM. Organotypic and Microphysiological Human Tissue Models for Drug Discovery and Development-Current State-of-the-Art and Future Perspectives. Pharmacol Rev 2022;74:141-206. [PMID: 35017176 DOI: 10.1124/pharmrev.120.000238] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Guizze F, Serra CHR, Giarolla J. PAMAM Dendrimers: A Review of Methodologies Employed in Biopharmaceutical Classification. J Pharm Sci 2022:S0022-3549(22)00301-X. [PMID: 35850238 DOI: 10.1016/j.xphs.2022.07.009] [Reference Citation Analysis]
13 O'Shea JP, Augustijns P, Brandl M, Brayden DJ, Brouwers J, Griffin BT, Holm R, Jacobsen AC, Lennernäs H, Vinarov Z, O'Driscoll CM. Best practices in current models mimicking drug permeability in the gastrointestinal tract - an UNGAP review. Eur J Pharm Sci 2021;:106098. [PMID: 34954051 DOI: 10.1016/j.ejps.2021.106098] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Schultz EM, Jones TJ, Xu S, Dean DD, Zechmann B, Barr KL. Cerebral Organoids Derived from a Parkinson's Patient Exhibit Unique Pathogenesis from Chikungunya Virus Infection When Compared to a Non-Parkinson's Patient. Pathogens 2021;10:913. [PMID: 34358063 DOI: 10.3390/pathogens10070913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lemmens G, Van Camp A, Kourula S, Vanuytsel T, Augustijns P. Drug Disposition in the Lower Gastrointestinal Tract: Targeting and Monitoring. Pharmaceutics 2021;13:161. [PMID: 33530468 DOI: 10.3390/pharmaceutics13020161] [Reference Citation Analysis]
16 Zhao Y, Lou J, Zhang H, Sun H, Zhang M, Wang S, Sha X, Zhan Z, Wang Y, Ma C, Li WJ. Measurement methods of single cell drug response. Talanta 2021;:123035. [PMID: 34839926 DOI: 10.1016/j.talanta.2021.123035] [Reference Citation Analysis]
17 Zietek T, Giesbertz P, Ewers M, Reichart F, Weinmüller M, Urbauer E, Haller D, Demir IE, Ceyhan GO, Kessler H, Rath E. Organoids to Study Intestinal Nutrient Transport, Drug Uptake and Metabolism - Update to the Human Model and Expansion of Applications. Front Bioeng Biotechnol 2020;8:577656. [PMID: 33015026 DOI: 10.3389/fbioe.2020.577656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
18 González-orozco BD, García-cano I, Jiménez-flores R, Alvárez VB. Invited review: Milk kefir microbiota—Direct and indirect antimicrobial effects. Journal of Dairy Science 2022. [DOI: 10.3168/jds.2021-21382] [Reference Citation Analysis]
19 Franco YL, Da Silva L, Cristofoletti R. Navigating Through Cell-Based In vitro Models Available for Prediction of Intestinal Permeability and Metabolism: Are We Ready for 3D? AAPS J 2021;24:2. [PMID: 34811603 DOI: 10.1208/s12248-021-00665-y] [Reference Citation Analysis]
20 Torres CE, Cifuentes J, Gómez SC, Quezada V, Giraldo KA, Puentes PR, Rueda-gensini L, Serna JA, Muñoz-camargo C, Reyes LH, Osma JF, Cruz JC. Microfluidic Synthesis and Purification of Magnetoliposomes for Potential Applications in the Gastrointestinal Delivery of Difficult-to-Transport Drugs. Pharmaceutics 2022;14:315. [DOI: 10.3390/pharmaceutics14020315] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Fedi A, Vitale C, Ponschin G, Ayehunie S, Fato M, Scaglione S. In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: A systematic review. J Control Release 2021;335:247-68. [PMID: 34033859 DOI: 10.1016/j.jconrel.2021.05.028] [Reference Citation Analysis]
22 Lambré C, Barat Baviera JM, Bolognesi C, Chesson A, Cocconcelli PS, Crebelli R, Gott DM, Grob K, Lampi E, Mengelers M, Mortensen A, Steffensen I, Tlustos C, Van Loveren H, Vernis L, Zorn H, Castle L, Di Consiglio E, Franz R, Hellwig N, Milana MR, Merkel S, Barthélémy E, Rivière G; EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP). Safety assessment of the active substances cyclooctene homopolymer and cobalt stearate in combination for use in active food contact materials. EFS2 2022;20. [DOI: 10.2903/j.efsa.2022.7364] [Reference Citation Analysis]